Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2670 of 6351
-
New pill takes on advanced cancers in early trial
Disease control Not yet recruitingAn open-label, multicenter phase I/IIa clinical study evaluating the safety, tolerability, pharmacokinetics, and preliminary efficacy of ZL-85FA tablets in treating advanced solid tumors
Phase 1/2 • Sponsor: Chengdu Zenitar Biomedical Technology Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Nanotech patch aims to slash opioid use after wisdom tooth surgery
Symptom relief Not yet recruitingThis is a randomized (1:1), placebo-controlled clinical trial that will examine the feasibility and effectiveness of a 2-day application of the NeuroCuple device for pain relief and reduction of opioid use following wisdom teeth extraction. The primary objectives are to determine…
Sponsor: nCap Medical • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
New drug HLX48 enters first human trial for Hard-to-Treat cancers
Disease control Recruiting nowThis study is an open-label first-in-human phase I clinical study to evaluate the safety, tolerability, and pharmacokinetic characteristics of HLX48 in patients with advanced/metastatic solid tumors.
Phase 1 • Sponsor: Shanghai Henlius Biotech • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Can blood tests and scans track lymphoma in real time? new study aims to find out.
Knowledge-focused Not yet recruitingRT4 (REAL TIME TAILORED THERAPY) study was designed as a national, multicenter proof of concept aiming to demonstrate the technical and operational capacity of the French Connect network and the Positron Emission Tomography (PET) review network to ensure, within a coordinated fra…
Sponsor: The Lymphoma Academic Research Organisation • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:08 UTC
-
Could a brain ZAP and rehab combo ease movement problems?
Symptom relief Recruiting nowThe purpose of this project is to evaluate feasibility and preliminary efficacy of pairing personalized transcranial direct current stimulation (tDCS) with individualized rehabilitation therapy in people with cerebellar damage.
Sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
Zapping the brain to ease Schizophrenia's 'Negative' symptoms?
Symptom relief Recruiting nowThis randomized, double-blind, sham-controlled trial aims to evaluate the efficacy and safety of dorsal anterior cingulate cortex-targeted temporal interference stimulation in individuals with schizophrenia. Participants will be randomly assigned to receive either active or sham …
Sponsor: Shanghai Pudong New Area Mental Health Center, School of Medicine, Tongji University • Aim: Symptom relief
Last updated Aug 23, 2026 00:00 UTC
-
Laser vs shock wave: which zaps shoulder pain better?
Symptom relief Not yet recruitingThis study will be conducted to investigate the difference between high-intensity laser and extracorporeal shock wave on supraspinatus tendon thickness, subacromial space, occupation ratio, shoulder pain intensity, shoulder range of motion (ROM), hand strength, and functional dis…
Sponsor: Cairo University • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Womb waves: could uterine contractions predict IVF success?
Knowledge-focused Recruiting nowEndometrial peristalsis may influence embryo implantation and pregnancy outcomes, but its role during hormone replacement therapy (HRT)-prepared frozen embryo transfer (FET) cycles remains unclear. This prospective observational study will assess endometrial peristalsis at predef…
Sponsor: Mỹ Đức Hospital • Aim: Knowledge-focused
Last updated Jul 11, 2026 00:00 UTC
-
New biosimilar aims to offer cheaper option for colorectal cancer
Disease control Not yet recruitingThis is a multicentre, randomized, double-blind, parallel-controlled Phase 1 clinical study designed to evaluate the pharmacokinetic (PK) similarity, efficacy, safety, and immunogenicity of HLX05-N compared with US-sourced ERBITUX® and EU-sourced ERBITUX® in participants with met…
Phase 1 • Sponsor: Shanghai Henlius Biotech • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New balance therapy for concussion patients put to the test
Knowledge-focused Not yet recruitingThis work will address an important gap in physical therapy rehabilitation after concussion. Physical therapy usually focuses on how the brain processes sensory information such as inner ear and vision for balance rehabilitation, but our recent research shows that people with imb…
Sponsor: Oregon Health and Science University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Soothing sounds may soothe tiny hearts after surgery
Symptom relief Recruiting nowChest tube removal in infants undergoing surgery for congenital heart disease is an invasive procedure associated with significant pain and physiological stress responses. This randomized controlled trial evaluates the effects of music and musical mobile interventions on pain and…
Sponsor: Baskent University • Aim: Symptom relief
Last updated Sep 05, 2026 00:00 UTC
-
Could a simple drug switch transform heart care in rural tanzania?
Disease control Recruiting nowAngiotensin-neprilysin inhibitors (ARNI) are beneficial in patients with heart failure with reduced ejection fraction. No study evaluating ARNI has been conducted in sub-Saharan Africa (except South Africa) yet, where heart failure is a major health problem. Before implementing A…
Phase 4 • Sponsor: Martin Rohacek • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Brain training game aims to reduce repetitive behaviors in autistic kids
Knowledge-focused Not yet recruiting95 autistic children (ages 8-11yrs) will be randomly assigned to a novel computer-based Cognitive Control Training combined with Metacognition Coaching or to a comparison group that receives the intervention after a delay. Before and after intervention, electroencephalography (EE…
Sponsor: Boston Children's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
New drug HRS-1635 enters early human testing for hard-to-treat blood cancers
Disease control Recruiting nowThe study is being conducted to evaluate the safety and tolerability of HRS-1635. To observe the Dose-Limiting Toxicity (DLT) , explore the Maximum Tolerated Dose (MTD, if possible) and the Recommended Phase 2 Dose (RP2D). This study also preliminarily evaluated the efficacy of H…
Phase 1 • Sponsor: Chengdu Suncadia Medicine Co., Ltd. • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New study aims to crack the code of treatment resistance in lymphoma
Knowledge-focused Not yet recruitingBispecific antibodies have demonstrated high efficacy in the treatment of Refractory/relapsed b-cell non-Hodgkin lymphomas. However, a non-negligible percentage of patients do not respond to therapy and/or develop significant treatment toxicity.
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Experimental combo aims to tackle returning brain tumors
Disease control Not yet recruitingThis study will test the hypothesis that vorasidenib in combination with lomustine will be safe and tolerable. The overall goal of this study is to identify the optimal vorasidenib dose that can be tested in a subsequent phase 2 study to determine the efficacy of vorasidenib in c…
Phase 1 • Sponsor: Megan Mantica • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Immunotherapy combo eyed as Pre-Surgery option for rare eye cancer
Disease control Recruiting nowThe goal of this clinical trial is to investigate the safety and feasibility of neoadjuvant immunotherapy for patients with high-risk uveal melanoma. The main question is: \- Is neoadjuvant treatment with nivolumab and ipilimumab safe and feasible for patientt with high-riks uve…
Phase 1 • Sponsor: Inge Marie Svane • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Peanut allergy patch enters human safety trials
Disease control Recruiting nowThe goal of this open-label, single escalating dose study in 3 sequential groups: adults, adolescents, and children with peanut allergy is to assess the safety of MOON101. The main question it aims to answer is: 1. the incidence and frequency of all treatment emergent adverse ev…
Phase 1 • Sponsor: Moonlight Therapeutics, Inc. • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Could a supplement that mimics human muscle boost strength and speed recovery?
Symptom relief Recruiting nowThis pilot randomized controlled trial evaluates HME (Human Muscle Equivalent), a free-form amino acid supplement formulated to match the amino acid composition of human skeletal muscle, taken at its Health Canada licensed dose (3 g powder plus one 50 mg slow-release beta-alanine…
Sponsor: Orivian inc • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC
-
Can a specific stretch ease nerve pain in the neck? a trial puts two methods to the test
Symptom relief Recruiting nowCervical radicular pain (CRP) is a musculoskeletal condition characterized by neck pain radiating to the upper limb due to compression or irritation of cervical nerve roots. It significantly affects daily activities, cervical mobility, and overall quality of life. Conventional ph…
Sponsor: Lahore University of Biological and Applied Sciences • Aim: Symptom relief
Last updated Jul 26, 2026 00:00 UTC